Uncategorized

September 14, 2023

Indian pharma industry to log in 8-10 pc revenue growth this fiscal: Crisil

In the ongoing fiscal, domestic sales are expected to witness 8-10 per cent growth with the chronic segment expected to be the key contributor to revenues, […]
June 6, 2023

Pharma companies may soon be required to list excipients on medication strips.

People in the know told ET that India’s medication regulatory agency is actively exploring enforcing mention of excipients on the strip of a medicine for its […]
June 3, 2023

Results from a mid-stage experiment give the BioNTech and OncoC4 alliance a strong start.

Patients with metastatic non-small cell lung cancer who were no longer responding to a class of medications known as checkpoint inhibitors, including Merck & Co.’s Keytruda, […]
June 2, 2023

AstraZeneca’s anti-liver cancer medication combination has received CDSCO approval.

Overall survival (OS) for the combination versus sorafenib was the primary endpoint, while secondary objectives for the combination and Durvalumab alone were OS for Durvalumab over […]
May 29, 2023

Ten HP-made medications are found to be subpar by a central regulator.

Himachal Pradesh is home to 660 pharmaceutical businesses, the majority of which are situated in the Baddi Barotiwala-Nalagarh region. Rajni Bhargava, the owner of the Cyper […]
May 27, 2023

US FDA approves Lexicon Pharma’s drug for heart failure

The oral drug, sotagliflozin, is the company’s first to be approved by the US health agency and will be sold under the brand name Inpefa. It […]
May 11, 2023

Franchise Monopoly of PCD Pharma

What Is the PCD Pharma Franchise Monopoly Basis? PCD Pharma Franchise Monopoly Basis: PCD Pharma Franchise is one of the major forces behind the impressive expansion […]
May 4, 2023

Investigating the Assam PCD Pharma Franchise Potential: A Profitable Business Opportunity.

One of the areas with the strongest growth rates worldwide is the pharmaceutical business, and India is no exception. The Indian pharmaceutical market is anticipated to […]
May 2, 2023

US FDA suspends Sun Pharma’s dermatological drug trial.

Deuruxolitinib 12 mg dosage should be stopped by individuals with alopecia areata, an autoimmune disorder that causes patchy hair loss, according to the FDA, according to […]